Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DX25F6XRJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $18,488
Award facts
- Contract value 100% obligated
- $18,488.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $18,488.12 on August 22, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). This firm fixed-price delivery order, with an ultimate completion date of August 25, 2025, was issued without a set-aside designation by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical procurement and distribution to military healthcare facilities. The contract represents a discrete purchase order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026.
Trikafta is a combination therapy medication used primarily in the treatment of cystic fibrosis, reflecting the Defense Logistics Agency's ongoing procurement of specialized pharmaceutical products to support the comprehensive medical needs of Department of Defense healthcare sites worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent contract performance delivering branded and generic prescription drugs, biologics, and medical consumables to military health facilities. The company's status as a woman-owned small business and its established presence in federal markets since 2001 have enabled it to compete effectively for delivery orders across the Defense Logistics Agency's extensive pharmaceutical product portfolio.
Quick answers
Who was awarded contract SPE2DX25F6XRJ?
SPE2DX25F6XRJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 22, 2025.
How much is contract SPE2DX25F6XRJ worth?
The government has obligated $18,488 on SPE2DX25F6XRJ.
Is contract SPE2DX25F6XRJ an order under another contract?
Yes. SPE2DX25F6XRJ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRJ competed?
The extent of competition for SPE2DX25F6XRJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award